Literature DB >> 1558416

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

P Damas1, D Ledoux, M Nys, Y Vrindts, D De Groote, P Franchimont, M Lamy.   

Abstract

Forty critically ill surgical patients with documented infections were studied during their stay in an intensive care unit. Among these patients, 19 developed septic shock and 16 died, 9 of them from septic shock. Interleukin 1 beta (IL-1 beta), tumor necrosis factor (TNF alpha), and interleukin 6 (IL-6) were measured each day and every 1 or 2 hours when septic shock occurred. Although IL-1 beta was never found, TNF alpha was most often observed in the serum at a level under 100 pg/mL except during septic shock. During these acute episodes TNF alpha level reached several hundred pg/mL, but only for a few hours. In contrast, IL-6 was always increased in the serum of acutely ill patients (peak to 500,000 pg/mL). There was a direct correlation between IL-6 peak serum level and TNF alpha peak serum level during septic shock and between IL-6 serum level and temperature or C-reactive protein serum level. Moreover, IL-6 correlated well with APACHE II score, and the mortality rate increased significantly in the group of patients who presented with IL-6 serum level above 1000 pg/mL. Thus, IL-6 appears to be a good marker of severity during bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558416      PMCID: PMC1242452          DOI: 10.1097/00000658-199204000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

1.  Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group.

Authors:  T Calandra; J D Baumgartner; G E Grau; M M Wu; P H Lambert; J Schellekens; J Verhoef; M P Glauser
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

Review 2.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

4.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

5.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.

Authors:  K Ohlsson; P Björk; M Bergenfeldt; R Hageman; R C Thompson
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

6.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

8.  Tumor necrosis factor mediates endotoxic effects in mice.

Authors:  F Bauss; W Dröge; D N Männel
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

9.  A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.

Authors:  G Wakabayashi; J A Gelfand; J F Burke; R C Thompson; C A Dinarello
Journal:  FASEB J       Date:  1991-03-01       Impact factor: 5.191

10.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.

Authors:  J C Mathison; E Wolfson; R J Ulevitch
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more
  184 in total

1.  Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.

Authors:  Sachin S Kale; Sachin Yende
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1).

Authors:  Matthew T Rondina; BreAnna Brewster; Colin K Grissom; Guy A Zimmerman; Diana H Kastendieck; Estelle S Harris; Andrew S Weyrich
Journal:  Chest       Date:  2012-03-01       Impact factor: 9.410

3.  Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patients.

Authors:  Michael N Cocchi; Brandon Giberson; Katherine Berg; Justin D Salciccioli; Ali Naini; Catherine Buettner; Praveen Akuthota; Shiva Gautam; Michael W Donnino
Journal:  Resuscitation       Date:  2012-03-28       Impact factor: 5.262

4.  A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury.

Authors:  Brian D Kubiak; Scott P Albert; Louis A Gatto; Christopher J Vieau; Shreyas K Roy; Kathleen P Snyder; Kristopher G Maier; Gary F Nieman
Journal:  J Surg Res       Date:  2010-11-12       Impact factor: 2.192

5.  Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis.

Authors:  Li Zhang; Shengwei Jin; Changdong Wang; Rong Jiang; Jingyuan Wan
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

6.  Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  Ryohei Watanabe; Tetsuya Matsumoto; Go Sano; Yoshikazu Ishii; Kazuhiro Tateda; Yoshinobu Sumiyama; Jumpei Uchiyama; Shingo Sakurai; Shigenobu Matsuzaki; Shosuke Imai; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

7.  Leukocyte function-associated antigen-1 deficiency impairs responses to polymicrobial sepsis.

Authors:  Jia-Ren Liu; Xiaohui Han; Sulpicio G Soriano; Koichi Yuki
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

8.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

9.  Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients.

Authors:  Adrian Billeter; Matthias Turina; Burkhardt Seifert; Ladislav Mica; Reto Stocker; Marius Keel
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

10.  Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Beata Smolarz; Hanna Romanowicz-Makowska; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.